최제용 교수(의과대학 의학과)
o (1988) B.S., Kyungpook National University(KNU), Dentistry, Daegu, South Korea
o (1990) M.A., Kyungpook National University, Biochemistry
o (1994) Ph.D., Kyungpook National University, Biochemistry
o (2021~present) Professor, Department of Biochemistry & Cell Biology, School of Medicine, KNU, Daegu, Korea
o (2018~2021) Advisory board member, Science and Technology Policy Institute (STEPI), Korea
o (2017~2018) Director, Industry and Academic Cooperation Foundation, KNU, Korea
o (2019~present) Director, Laboratory Animal Resources in KNU, Daegu, Korea
o (2008~2009) Visiting Professor, Graduate School of Medicine, University of Tokyo, Japan
o (2019~present) Director, Laboratory Animal Resources in KNU, Korea
o (1998~1999) Instructor, Massachusetts Medical School, USA
o (1996~1998) Postdoctoral Researcher, Massachusetts Medical School, USA
Osteoarthritis,
Osteoporosis,
Vascular Calcification,
Bone Cell Biology,
Biomineralization,
Runx/Cbfb transcription factors,
Mouse genetics
o Essential roles for Cbfb in osteoblast formation and chondrocyte maturation by Runx2 and in articular chondrocyte maintenance by Runx1.
o Various biological applications of 4-Hexylresorcinol, including anticancer, anti-inflammatory, and biocompatibility enhancing functions.
o Establishment of a mouse vascular calcification (VC) model using high dose vitamin D and identifying the essential role of Runx2 and VDR in VC.
o Essential role of the Runx2 carboxyl terminus for subnuclear targeting, osteoblast formation, and chondrocyte maturation during skeletal tissue development